Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02617173
Other study ID # SHEBA-15-2514-GR-CTIL
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 22, 2015
Last updated November 26, 2015
Start date November 2015
Est. completion date January 2017

Study information

Verified date November 2015
Source Sheba Medical Center
Contact Gil Raviv, Prof
Phone 972-52-666-8285
Email Gil.Raviv@sheba.health.gov.il
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

Oligozoospermia, refers to a low concentration of sperm. A low sperm count or poor sperm quality is the cause of infertility in about 20% of couples with fertility problems, and a contributory factor in a further 25% of couples. In the majority of cases, no cause can be found. For mild male infertility, intra uterine insemination (IUI) is the procedure of choice with a pregnancy rate of 6.5%. In IUI, sperm is inserted using a thin, flexible catheter directly into a woman's uterus.

Azoospermia affects 1% of the male population and 20% of male infertility situations. Over 50% of azoospermic cases are due to testicular failure, including absence or failed production as well as low production and maturation arrest during the process of spermatogenesis. ICSI allows successful fertilization even with immature sperm obtained directly from testicular tissue. This is done through TESA (Testicular sperm aspiration) or TESE (Testicular sperm extraction). In cases of TESE small strips of testicular tissue are extracted with the intention of finding few viable sperm cells to be used for IVF or ICSI. Men with non-obstructive azoospermia have 0 to 3 mature spermatids per seminiferous tubule in contrast to 17-35 mature spermatids in men with normal spermatogenesis. TESE success rates are approximately 50% but differ according to etiology. Unfortunately, there is no method of pointing out where sperm may be found. TESE is accompanied with pain, tissue loss, reduced success in future TESE due to tissue scaring and testosterone deficiency.

The complex process of spermatogenesis includes maturation of young spermatids into spermatozoas, a process which takes approximately 74 days. During spermatogenesis, spermatogonial stem cells are transformed into spermatids and released from the seminiferous tubule epithelium into its lumen. Non-motile spermatozoa are transported through the seminifreous tubules to the epididymis by testicular fluid secreted from the Sertoli cells with the aid of peristaltic contraction. During transport through the epididymis, sperm cells develop the ability to progress forward, undergo capacitation and attach and penetrate the egg.

The electric charge of the spermatic cell has been termed zeta potential (electrokinetic potential) and is defined as the electric potential in the slip plane between the sperm membrane and its surroundings. Mature sperm possess an electric charge of −16 to −20 mV.

In the animal study conducted, positive electrical current with a low amplitude bellow sensation level was situated around the scrotum of four normospermic and one oligospermic male pigs. At the end of the research the concentration of spermatocytes in the epididymis obtained in surgery was found to be 200 to 1600 percent above the baseline.

Our intention is to evaluate if positive electrical current with a low amplitude bellow sensation level situated on the scrotum will increase the concentration of spermatocytes in the ejaculate.

If our hypothesis is confirmed this may become a method for treating male infertility. The period of improvement is still unclear.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date January 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Male
Age group 21 Years to 45 Years
Eligibility Inclusion Criteria:

- Men with primary infertility defined as a state of Azoospermia.

- Men with pathological sperm tests indices as defined by the WHO.

Exclusion Criteria:

- Men with genetic syndromes, and states of Azoospermia secondary to chemotherapy, bone marrow transplantation or radiation.

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Micro 400 Matrix Therapy Products
Positive electrical current with a low amplitude bellow sensation level situated on the scrotum.

Locations

Country Name City State
Israel Male Fertility Clinic, Sheba Medical Center Ramat Gan

Sponsors (1)

Lead Sponsor Collaborator
Sheba Medical Center

Country where clinical trial is conducted

Israel, 

References & Publications (2)

Chan PJ, Jacobson JD, Corselli JU, Patton WC. A simple zeta method for sperm selection based on membrane charge. Fertil Steril. 2006 Feb;85(2):481-6. — View Citation

Ishijima SA, Okuno M, Mohri H. Zeta potential of human X- and Y-bearing sperm. Int J Androl. 1991 Oct;14(5):340-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Spermatomcyte count in the ejaculate. To evaluate if positive electrical current with a low amplitude below sensation level situated on the scrotum will increase the concentration of spermatocytes in the ejaculate. One year. No
See also
  Status Clinical Trial Phase
Completed NCT04675164 - Laser Assisted Sperm Selection of Viable Immotile Testicular Sperm in Azoospermic Infertile Men N/A
Completed NCT01375062 - Obtaining Undifferentiated Cells From Testis Biopsy N/A
Active, not recruiting NCT05134428 - Safety Evaluation of the ADAM System N/A
Active, not recruiting NCT05866484 - Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
Enrolling by invitation NCT03762967 - Autologous Adipose-Derived Adult Stromal Vascular Cell Administration for Male Patients With Infertility Phase 2
Completed NCT00484081 - Microdissection Testicular Sperm Extraction (MicroTESE) and IVF-ICSI Outcome in Non-Obstructive Azoospermia (NOA) N/A
Recruiting NCT02418832 - Testis Needle Aspiration of Sperm in Men With Azoospermia N/A
Recruiting NCT02041910 - Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia Phase 1/Phase 2
Recruiting NCT02008799 - Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia N/A
Completed NCT01509482 - Insulin Resistance in Idiopathic Oligospermia and Azoospermia N/A
Completed NCT02339272 - Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility N/A
Completed NCT00548977 - Genetic Studies Spermatogenic Failure N/A
Recruiting NCT05479474 - Platelet Rich Plasma Testis Treatment for Infertile Men N/A
Not yet recruiting NCT02275169 - FSH Treatment for Non-obstructive Azoospermic Patients Phase 3
Recruiting NCT00282477 - Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls Phase 2
Recruiting NCT05628987 - The Association of Gut Microbiota and Spermatogenic Dysfunction
Recruiting NCT02544191 - GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia Phase 2
Enrolling by invitation NCT02307994 - Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSH Phase 4
Completed NCT02414295 - Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection N/A
Terminated NCT02773498 - Comparison of Medical Results of Testicular Sperm Extraction by Conventional Surgery and Microsurgical Track N/A